ARRDC1
Arrestin domain-containing protein 1
Also known as: ARRD1_HUMAN, MGC40555
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N5I2
- Gene
- ARRDC1
- Ensembl
- ENSG00000197070
- Chromosome
- 9
- Canonical length
- 433 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables several functions, including arrestin family protein binding activity; ubiquitin protein ligase binding activity; and ubiquitin-like ligase-substrate adaptor activity. Involved in several processes, including extracellular vesicle biogenesis; negative regulation of Notch signaling pathway; and ubiquitin-dependent protein catabolic process. Located in cytoplasmic vesicle; extracellular vesicle; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
433 residues, UniProt reviewed canonical sequence.
>Q8N5I2|ARRDC1
1 MGRVQLFEIS LSHGRVVYSP GEPLAGTVRV RLGAPLPFRA IRVTCIGSCG VSNKANDTAW
61 VVEEGYFNSS LSLADKGSLP AGEHSFPFQF LLPATAPTSF EGPFGKIVHQ VRAAIHTPRF
121 SKDHKCSLVF YILSPLNLNS IPDIEQPNVA SATKKFSYKL VKTGSVVLTA STDLRGYVVG
181 QALQLHADVE NQSGKDTSPV VASLLQKVSY KAKRWIHDVR TIAEVEGAGV KAWRRAQWHE
241 QILVPALPQS ALPGCSLIHI DYYLQVSLKA PEATVTLPVF IGNIAVNHAP VSPRPGLGLP
301 PGAPPLVVPS APPQEEAEAE AAAGGPHFLD PVFLSTKSHS QRQPLLATLS SVPGAPEPCP
361 QDGSPASHPL HPPLCISTGA TVPYFAEGSG GPVPTTSTLI LPPEYSSWGY PYEAPPSYEQ
421 SCGGVEPSLT PESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARRDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 60 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 60 nTPM
- spleen: 53 nTPM
- stomach: 52 nTPM
- salivary gland: 51 nTPM
- liver: 43 nTPM
- prostate: 43 nTPM
Single-cell type
- renal collecting duct principal cells: 59 nCPM
- papillary tip epithelial cells: 57 nCPM
- esophageal apical cells: 51 nCPM
- breast lactating cells: 50 nCPM
- loop of henle epithelial cells: 35 nCPM
- cytotrophoblasts: 31 nCPM
Immune cell
- eosinophil: 215 nTPM
- intermediate monocyte: 133 nTPM
- non-classical monocyte: 123 nTPM
- myeloid DC: 122 nTPM
- basophil: 110 nTPM
- classical monocyte: 99 nTPM
Brain region
- choroid plexus: 16 nTPM
- hippocampal formation: 12 nTPM
- cerebral cortex: 11 nTPM
- medulla oblongata: 11 nTPM
- pons: 11 nTPM
- basal ganglia: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.12
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- extracellular transport
- extracellular vesicle biogenesis
- negative regulation of Notch signaling pathway
- protein transport
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- arrestin family protein binding
- identical protein binding
- ubiquitin protein ligase binding
- ubiquitin-like ligase-substrate adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARRDC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARRDC1 as an antibody target. Whether an autoantibody or antibody against ARRDC1 could matter depends on whether native ARRDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARRDC1 is annotated at the cell surface, where native ARRDC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARRDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...